Today's Pre-Market Stock Movers: PLNT, RIDE, LYFT, TRIP and More
$Qiagen NV (QGEN.US)$ +3.4% (the biotech company raised its full-year outlook, pointing to particular strength in its non-Covid product portfolio.)
$Lordstown Motors (RIDE.US)$ +14.6% (contract manufacturer Foxconn will invest up to $170 million in the electric vehicle maker and become its largest shareholder.) $DuPont (DD.US)$ +3.7% (the industrial materials maker beat top and bottom line estimates for the third quarter. DuPont’s upbeat results came despite higher costs for raw materials and energy.)
$Planet Fitness (PLNT.US)$ +7.1% (The company's quarterly revenue and profit beat Wall Street estimates and it raised its full-year forecast. Its membership reached record highs during the quarter, with members visiting more frequently.) $Coty Inc (COTY.US)$ +3.2% (The cosmetics company reported earnings that matched Wall Street estimates, with revenue slightly above analysts’ forecasts. Demand for Coty’s products held up despite higher prices, although it did take a hit from a stronger U.S. dollar.)
$Take-Two Interactive Software (TTWO.US)$ -17.4% (the videogame publishercut its bookings outlook for the year. Take-Two has been impacted by weaker mobile and in-game sales, although CEO Strauss Zelnick said the situation should improve within the next three to six months.)
$Lyft Inc (LYFT.US)$ -17.3% (its latest quarterly report showed slowing revenue growth and ridership levels that remain below pre-pandemic levels. The ride-hailing service did, however, report better-than-expected earnings for its latest quarter.) $TripAdvisor (TRIP.US)$ -20.8% (the travel website operator’s quarterly earnings came in below Wall Street forecasts. TripAdvisor said currency fluctuations had a meaningful negative impact on revenue and that travel demand remains strong.) $Perrigo (PRGO.US)$ -3.2% (The over-the-counter drug and health products maker fell short on both the top and bottom lines for its latest quarter, and it also lowered its full-year forecast. Labor shortages and a stronger U.S. dollar were among the factors weighing on Perrigo’s results.)
$Medtronic (MDT.US)$ -5.5% (the release of study results involves a device aimed at tough-to-treat hypertension. The device did reduce blood pressure in patients, but only slightly more than medications to treat the ailment.)
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more9
lightfoot : Marketing. High cost of travel and food, the market will dip on these items reducing sales and bottom line. if they have cash can ride out the storm. Concentrate on products moving